content_image/67493.jpg
The following pro forma information is provided for information purposes and does not represent the historical results of Edwards Lifesciences as reported in the Company’s filings with the Securities and Exchange Commission. 

The following table sets forth the consolidated statements of operations, excluding certain items as detailed on page S30. This table should be read in conjunction with Edwards Lifesciences’ “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and 

## UNAUDITED PRO FORMA CONSOLIDATED STATEMENTS OF OPERATIONS 

“Consolidated Financial Statements” found elsewhere in this Annual Report to Shareholders. Results prior to April 1, 2000 are pro forma as Edwards Lifesciences was part of Baxter through the close of business on March 31, 2000. See Note 4 to the “Consolidated Financial Statements” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” for further discussions of the effects of certain asset divestitures on Edwards Lifesciences’ operations. 

<img src='content_image/67493.jpg'>

